These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
152 related items for PubMed ID: 2784107
1. Absence of homologous restriction factor does not affect CTL-mediated cytolysis. Krähenbühl OP, Peter HH, Tschopp J. Eur J Immunol; 1989 Jan; 19(1):217-9. PubMed ID: 2784107 [Abstract] [Full Text] [Related]
2. Resistance of cytolytic lymphocytes to perforin-mediated killing. Murine cytotoxic T lymphocytes and human natural killer cells do not contain functional soluble homologous restriction factor or other specific soluble protective factors. Jiang S, Persechini PM, Perussia B, Young JD. J Immunol; 1989 Sep 01; 143(5):1453-60. PubMed ID: 2503557 [Abstract] [Full Text] [Related]
3. Differential susceptibility of type III erythrocytes of paroxysmal nocturnal hemoglobinuria to lysis mediated by complement and perforin. Jiang S, Persechini PM, Rosse WF, Perussia B, Young JD. Biochem Biophys Res Commun; 1989 Jul 14; 162(1):316-25. PubMed ID: 2751655 [Abstract] [Full Text] [Related]
4. Paroxysmal nocturnal hemoglobinuria type III. Lack of an erythrocyte membrane protein restricting the lysis by C5b-9. Hänsch GM, Schönermark S, Roelcke D. J Clin Invest; 1987 Jul 14; 80(1):7-12. PubMed ID: 3597779 [Abstract] [Full Text] [Related]
5. Structural/functional similarity between proteins involved in complement- and cytotoxic T-lymphocyte-mediated cytolysis. Tschopp J, Masson D, Stanley KK. Nature; 1987 Jul 14; 322(6082):831-4. PubMed ID: 2427956 [Abstract] [Full Text] [Related]
6. Erythrocyte membrane protein deficiencies in paroxysmal nocturnal hemoglobinuria. Schultz DR. Am J Med; 1989 Sep 14; 87(3N):22N-29N. PubMed ID: 2484793 [Abstract] [Full Text] [Related]
11. [Cytotoxic molecules, perforin and serine esterase in cytotoxic T lymphocyte]. Koizumi H. Arerugi; 1989 Jan 14; 38(1):41-8. PubMed ID: 2787151 [Abstract] [Full Text] [Related]
15. Resistance of cytolytic lymphocytes to perforin-mediated killing. Lack of correlation with complement-associated homologous species restriction. Jiang SB, Persechini PM, Zychlinsky A, Liu CC, Perussia B, Young JD. J Exp Med; 1988 Dec 01; 168(6):2207-19. PubMed ID: 3199067 [Abstract] [Full Text] [Related]
18. Distinct restriction of complement- and cell-mediated lysis. Hollander N, Shin ML, Rosse WF, Springer TA. J Immunol; 1989 Jun 01; 142(11):3913-6. PubMed ID: 2785570 [Abstract] [Full Text] [Related]
19. Synergistic inhibition of human cell-mediated cytotoxicity by complement component antisera indicates that target cell lysis may result from an enzymatic cascade involving granzymes and perforin. Brahmi Z, Csipo I, Bochan MR, Su B, Montel AH, Morse PA. Nat Immun; 1995 Sep 01; 14(5-6):271-85. PubMed ID: 8933821 [Abstract] [Full Text] [Related]
20. Analysis of the effects of activation of the alternative pathway of complement on erythrocytes with an isolated deficiency of decay accelerating factor. Holguin MH, Martin CB, Bernshaw NJ, Parker CJ. J Immunol; 1992 Jan 15; 148(2):498-502. PubMed ID: 1370313 [Abstract] [Full Text] [Related] Page: [Next] [New Search]